These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20367224)

  • 1. Hypertension, obesity, and inflammation: the complex designs of a deadly trio.
    Rizvi AA
    Metab Syndr Relat Disord; 2010 Aug; 8(4):287-94. PubMed ID: 20367224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance: trigger or concomitant factor in the metabolic syndrome.
    Avogaro A
    Panminerva Med; 2006 Mar; 48(1):3-12. PubMed ID: 16633326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome: role of skeletal muscle metabolism.
    Stump CS; Henriksen EJ; Wei Y; Sowers JR
    Ann Med; 2006; 38(6):389-402. PubMed ID: 17008303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2009 stock conference report: inflammation, obesity and metabolic disease.
    Hevener AL; Febbraio MA;
    Obes Rev; 2010 Sep; 11(9):635-44. PubMed ID: 20002885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, hypertension and insulin resistance.
    Sharma AM; Chetty VT
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S3-8. PubMed ID: 15868117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue, inflammation, and cardiovascular disease.
    Berg AH; Scherer PE
    Circ Res; 2005 May; 96(9):939-49. PubMed ID: 15890981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on obstructive sleep apnea and the metabolic syndrome.
    Lam JC; Ip MS
    Curr Opin Pulm Med; 2007 Nov; 13(6):484-9. PubMed ID: 17901753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the metabolic syndrome--a chronic cardiovascular inflammatory condition.
    Zambon A; Pauletto P; Crepaldi G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():20-3. PubMed ID: 16225466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.